Category: Blog

As we did during Covid, the government is helping U.S. companies to meet national-security needs.

Shares of the corporate stalwart plunged 25% as AI purchases crowd out traditional tech spending in many companies’ budgets.

Watch to see why companies are betting big on the therapeutic potential of a toad poison.

Plus, Apple’s legal sparring, and Wall Street’s problem with AI drug discovery.

IBM shares sank more than 25% as the company issued a profit warning citing a shift in customer spending from software to AI hardware and memory chips.

Gov. Kathy Hochul is banning their construction for up to a year, giving the state time to formulate regulations focused on the environment and the energy grid.

AstraZeneca entered into an exclusive global license agreement with China’s Dizal Pharmaceutical for the lung cancer treatment.

Dongfang Suanxin, or DFSX, introduced its self-designed AI chip—the DF1000—using a fully domestic supply chain to bypass restrictions on high-end technology that have hindered Chinese firms’ ability to produce cutting-edge … Read More

The social-media giant has flooded the market with its AI-enabled, camera-equipped smartglasses, much to the chagrin of privacy advocates.

Choosing safe, high-quality charging accessories can extend the lifespan of your devices and save you big money on repairs.